FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4360811000001101: Avelox 400mg tablets (Bayer Plc) 5 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26929501000001118 Avelox 400mg tablets (Bayer Plc) 5 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26929601000001119 Avelox 400mg tablets (Bayer Plc) 5 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Avelox 400mg tablets (Bayer Plc) 5 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Is a Moxifloxacin 400mg tablets 5 tablet true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Is pack of Avelox 400mg tablets (Bayer Plc) false Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has active ingredient Moxifloxacin hydrochloride false Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has AMP Avelox 400mg tablets (Bayer Plc) true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Moxifloxacin true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has specific active ingredient Moxifloxacin hydrochloride true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Avelox 400mg tablets (Bayer Plc) 5 tablet Has basis of strength substance Moxifloxacin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start